|
Apr 30
|
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 26
|
Bio-Rad Announces Life Science Group Management Changes
|
|
Apr 19
|
New Strong Sell Stocks for April 19th
|
|
Apr 18
|
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
|
|
Apr 18
|
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
|
|
Apr 17
|
Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week, taking three-year losses to 53%
|
|
Apr 16
|
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
|
|
Apr 13
|
OncoCyte Corp (OCX) Q4 2023 Earnings Call Transcript Highlights: Strategic Partnerships and ...
|
|
Apr 13
|
Q4 2023 OncoCyte Corp Earnings Call
|
|
Apr 11
|
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
|
|
Apr 11
|
Waters (WAT) Boosts Waters Operating Segment With HPLC System
|
|
Apr 10
|
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
|
|
Mar 28
|
Why Is Perrigo (PRGO) Up 19.1% Since Last Earnings Report?
|
|
Mar 20
|
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
|
|
Mar 18
|
Green Thumb Industries Inc. (GTBIF) Soars 11.3%: Is Further Upside Left in the Stock?
|
|
Mar 12
|
Bio-Rad (BIO) Suffers due to BioPharma Softness, Stiff Competition
|
|
Jan 2
|
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
|
|
Dec 20
|
6 Cheap Healthcare Stock Picks With Room to Grow in 2024
|
|
Dec 20
|
Bio-Rad (BIO) Faces Soft Industry-wide Demand, Macro Woes
|
|
Dec 18
|
Investors Aren't Entirely Convinced By Bio-Rad Laboratories, Inc.'s (NYSE:BIO) Revenues
|